Zhou, Wei
Huang, Ziyang
Xu, Kai
Li, Yamin
Li, Xiaoyu
Li, Jiaxian
Jin, Yu
Snellingen, Torkel
Liang, Lina http://orcid.org/0000-0003-2408-7852
Funding for this research was provided by:
National Natural Science Foundation of China (82274589, 81973912)
Science and Technology Innovation Project in China Academy of Chinese Medical Sciences (CI2021A02602)
China Center for Evidence-based Medicine of Traditional Chinese Medicine Special Project for Director of Business Research Office (2020YJSZX-2)
Article History
Received: 26 October 2023
Accepted: 16 January 2024
First Online: 27 January 2024
Declarations
:
: This trial will be in accordance by the Declaration of Helsinki and Ethical Guidelines for Clinical Research. The updated version of trial protocol (version 2.0, 1 December 2022) has been reviewed and approved on 23 December 2022 (YKEC-KT-2022–043-P002) by the ethics committee of Eye Hospital, China Academy of Chinese Medical Sciences, and registered in the Chinese Clinical Trial Registry. Informed consent will be obtained from all the study participants and their legal guardian. The study is in progress. All documents communicating with the ethics committee will be reposited by the principal investigator. Modifications of the protocol will be reviewed by the ethics committee and implemented after approval. Later results will be registered in ChiCTR and made available to participants in accordance with the terms described in the documents.
: Not applicable—no identifying images or other personal or clinical details of participants are presented here or will be presented in reports of the trial results. The participant information materials and informed consent form are available from the corresponding authors.
: The authors declare no competing interests.